- In March 2024, a research team led by Dr. Stavros Thomopoulos, a biomechanics professor at Columbia University, developed a novel device inspired by the unique structure of python teeth. This innovation enhances the strength of tendon-to-bone attachment during rotator cuff repair, minimizing the risk of re-tears and improving recovery outcomes for patients
- In May 2022, Embody, Inc. received FDA approval for its TAPESTRY RC device, a groundbreaking medical implant designed to treat rotator cuff injuries. This approval introduces an advanced treatment option, providing better tendon-to-bone healing, reduced complications, and a more effective pathway for patients to achieve improved recovery outcomes from rotator cuff injuries
- In May 2022, DePuy Synthes gained FDA 510(k) clearance for the INHANCE Shoulder System, a key innovation in the field of reverse total shoulder arthroplasty. This system offers surgeons enhanced tools to treat complex shoulder conditions, including rotator cuff damage, leading to improved patient mobility and long-term functional outcomes after surgery
- In January 2021, Stryker acquired OrthoSpace, Ltd., expanding its sports medicine portfolio with new solutions for rotator cuff tear therapy. This acquisition allows Stryker to integrate OrthoSpace's minimally invasive technologies, such as their unique balloon-based procedure, into its product offerings, improving the range of treatment options available for patients suffering from rotator cuff injuries
